• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于女性血管内介入治疗患者的新死亡率风险评分。

A novel mortality risk score for female patients undergoing endovascular interventions.

机构信息

Department of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA.

出版信息

J Interv Cardiol. 2011 Dec;24(6):555-61. doi: 10.1111/j.1540-8183.2011.00669.x. Epub 2011 Aug 25.

DOI:10.1111/j.1540-8183.2011.00669.x
PMID:21883472
Abstract

BACKGROUND

Peripheral arterial disease (PAD) has been described as a rising epidemic in recent years. The majority of subjects studied in PAD literature have been male, leaving female patients an underrepresented population with regard to revascularization outcomes. The goal of our study was to determine the death rate and predictors of mortality in female patients undergoing endovascular intervention (EI) for symptomatic PAD.

METHODS AND RESULTS

This study was conducted as a single-center retrospective chart review of 292 female patients who underwent EI for symptomatic PAD. Patient variables including demographics and procedural data were analyzed for statistical significance with regard to mortality. Age, history of congestive heart failure (CHF), and chronic kidney disease (CKD) were found to be significant predictors of mortality on multivariable analysis. A death risk score was formulated based on the above variables, risk stratifying patients into low, medium, or high risk groups for mortality after EI. Overall, 76 patients (26%) fell into the low risk category with a mortality of 5.3%, 102 patients (35%) fell into the moderate risk with a mortality of 15.7%, and 112 patients (39%) fell into the high-risk group with a mortality of 45.5% (P < 0.0001).

CONCLUSIONS

Our study is the first of its kind to specify predictors of mortality in female patients with symptomatic PAD. This study also provides a tool to identify female PAD patients at high risk for death after EI. Finally, it highlights the effect of CKD, age, and CHF on mortality of patients with PAD.

摘要

背景

近年来,周围动脉疾病(PAD)已被描述为一种日益流行的疾病。PAD 文献中的大多数研究对象都是男性,这使得女性患者在血运重建结果方面代表性不足。我们的研究目的是确定接受血管内介入(EI)治疗有症状 PAD 的女性患者的死亡率和死亡预测因素。

方法和结果

本研究是对 292 例接受 EI 治疗有症状 PAD 的女性患者进行的单中心回顾性图表回顾。对患者变量,包括人口统计学和程序数据进行分析,以确定与死亡率相关的统计学意义。多变量分析显示,年龄、充血性心力衰竭(CHF)病史和慢性肾脏病(CKD)是死亡率的显著预测因素。根据上述变量制定了死亡风险评分,将患者分为 EI 后死亡风险低、中、高的风险组。总的来说,76 例(26%)患者属于低危组,死亡率为 5.3%,102 例(35%)患者属于中危组,死亡率为 15.7%,112 例(39%)患者属于高危组,死亡率为 45.5%(P<0.0001)。

结论

我们的研究首次明确了有症状 PAD 女性患者的死亡预测因素。该研究还提供了一种工具,可识别接受 EI 治疗后死亡风险高的女性 PAD 患者。最后,它强调了 CKD、年龄和 CHF 对 PAD 患者死亡率的影响。

相似文献

1
A novel mortality risk score for female patients undergoing endovascular interventions.一种用于女性血管内介入治疗患者的新死亡率风险评分。
J Interv Cardiol. 2011 Dec;24(6):555-61. doi: 10.1111/j.1540-8183.2011.00669.x. Epub 2011 Aug 25.
2
Predictors of poor outcome in female patients undergoing endovascular intervention.女性患者血管内介入治疗预后不良的预测因素。
J Interv Cardiol. 2010 Aug;23(4):401-10. doi: 10.1111/j.1540-8183.2010.00548.x. Epub 2010 May 25.
3
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.当代经皮外周动脉介入治疗在老年人中的安全性:来自 BMC2 PVI(密歇根蓝十字蓝盾心血管联合会外周血管介入)注册研究的见解。
JACC Cardiovasc Interv. 2011 Jun;4(6):694-701. doi: 10.1016/j.jcin.2011.03.012.
4
Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.外周动脉疾病对急性心肌梗死后经皮冠状动脉介入治疗住院结局的影响。
Am J Cardiol. 2010 May 1;105(9):1268-71. doi: 10.1016/j.amjcard.2009.12.043. Epub 2010 Mar 11.
5
Peripheral arterial disease in patients with stages IV and V chronic renal failure.IV期和V期慢性肾衰竭患者的外周动脉疾病
Nephrol Dial Transplant. 2006 Dec;21(12):3525-31. doi: 10.1093/ndt/gfl470. Epub 2006 Aug 29.
6
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel.经皮冠状动脉介入治疗的慢性肾脏病患者心血管死亡率主要与氯吡格雷对 P2Y12 的抑制作用受损有关。
J Am Coll Cardiol. 2011 Jan 25;57(4):399-408. doi: 10.1016/j.jacc.2010.09.032.
7
Correlation between peripheral arterial disease and stage of chronic kidney disease.外周动脉疾病与慢性肾脏病分期之间的相关性。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S46-50.
8
Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.心源性休克患者在溶栓治疗失败后是否应接受补救性血管成形术:心源性休克患者直接血管成形术与补救性血管成形术的比较
J Invasive Cardiol. 2007 May;19(5):217-23.
9
A prognostic risk index for long-term mortality in patients with peripheral arterial disease.外周动脉疾病患者长期死亡率的预后风险指数
Arch Intern Med. 2007 Dec 10;167(22):2482-9. doi: 10.1001/archinte.167.22.2482.
10
Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study.无保护左主干病变患者冠状动脉血运重建术后长期临床结局的主要预测因素:来自 MAIN-COMPARE 研究的分析。
Circ Cardiovasc Interv. 2010 Apr;3(2):127-33. doi: 10.1161/CIRCINTERVENTIONS.109.890053.